InvestorsHub Logo
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

Re: None

Monday, 09/20/2021 10:25:34 AM

Monday, September 20, 2021 10:25:34 AM

Post# of 256
CRVS:When CD73 Antibody was Added to AZN's IMFINZI.the Decline in the Risk of Desease Progression or Death Stood @ 56% Compared to Only 35% with MONALIZUMAD-made by AZN/IPHA.
AZN Needs CRVS,s CD73 Antobody-Called MUPADOLIMAB-to Improve Patients Rresults from 35% to 56%-thus a Big Deal and brings CRVS's CD73 Asset Value to at Least $1B Mkt Cap.

Conference Call Nextweek
Angel Pharma Update
56% Tutes Holdings
Insider Buying

PPS To Double Digits cometh,jmhtto

Green with another High Trade Volume
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRVS News